Chung C.-S.Liao C.-H.Cheng S.-L.Lin T.-H.PO-REN HSUEH2020-12-182020-12-1820081684-1182https://scholars.lib.ntu.edu.tw/handle/123456789/528711Corynebacterium urealyticum, an infrequent cause of bacteremia, is an emerging pathogen in humans, especially immunocompromised hosts. This report describes a patient with prostate cancer complicated with obstructive nephropathy who developed C. urealyticum bacteremia after placement of a percutaneous nephrostomy tube. The bacteremia was not controlled until the infected nephrostomy tube was removed. ? 2008 Journal of Microbiology, Immunology and Infection.[SDGs]SDG3ampicillin; antibiotic agent; cefotaxime; penicillin G; sultamicillin; teicoplanin; vancomycin; aged; anuria; article; bacteremia; bacterial colonization; cancer localization; case report; clinical feature; Corynebacterium urealyticum; cystoscopy; disease association; drug substitution; drug withdrawal; hematuria; human; kidney disease; male; obstructive nephropathy; pathogenesis; percutaneous nephrostomy; prostate cancer; pyuria; recurrent disease; Taiwan; tube removal; urinary tract infection; urine culture; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Corynebacterium; Corynebacterium Infections; Humans; Male; Nephrostomy, Percutaneousjournal article192556982-s2.0-62149091809